Scarica l'app Stockscreener
6.41
2.40%
0.15
Pre-mercato:
6.79
0.38
+5.93%
Meiragtx Holdings Plc Borsa (MGTX) Ultime notizie
MeiraGTX CFO Richard Giroux sells $150,960 in ordinary shares - Investing.com India
Long Term Trading Analysis for (MGTX) - Stock Traders Daily
Is MeiraGTx Holdings plc (MGTX) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Insider Monkey
MeiraGTx (NASDAQ:MGTX) Trading 8% HigherWhat's Next? - MarketBeat
Barclays PLC Acquires 76,437 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Acquired by Barclays PLC - MarketBeat
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Sold by Jane Street Group LLC - Defense World
Contrasting Innate Pharma (OTCMKTS:IPHYF) and MeiraGTx (NASDAQ:MGTX) - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) CEO Sells $231,878.33 in Stock - MarketBeat
MeiraGTX president sells shares worth $305,342 By Investing.com - Investing.com Nigeria
Head-To-Head Survey: Tevogen Bio (NASDAQ:TVGN) and MeiraGTx (NASDAQ:MGTX) - Defense World
Geode Capital Management LLC Cuts Position in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
High Growth Tech Stocks in the United States - Simply Wall St
MeiraGTx Holdings plc (NASDAQ:MGTX) Stock Holdings Lifted by Barclays PLC - Defense World
State Street Corp Boosts Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
How the (MGTX) price action is used to our Advantage - Stock Traders Daily
MeiraGTx Holdings plc (MGTX): Is This Gene Therapy Stock a Good Buy Right Now? - Insider Monkey
(MGTX) Trading Signals - Stock Traders Daily
MeiraGTx (NASDAQ:MGTX) Shares Up 10.1%Here's Why - MarketBeat
BNP Paribas Financial Markets Raises Stock Holdings in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx's SWOT analysis: gene therapy firm's stock faces clinical hurdles - Investing.com
Garden State Investment Advisory Services LLC Invests $1.64 Million in MeiraGTx Holdings plc (NASDAQ:MGTX) - MarketBeat
Investors in MeiraGTx Holdings (NASDAQ:MGTX) have unfortunately lost 71% over the last five years - Yahoo Finance
MetLife Investment Management LLC Reduces Position in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx's SWOT analysis: gene therapy firm's stock faces pivotal year By Investing.com - Investing.com Nigeria
MeiraGTx granted RMAT designation by U.S. FDA to AAV2-hAQP1 - Yahoo Finance
Learn to Evaluate (MGTX) using the Charts - Stock Traders Daily
FDA grants RMAT status to MeiraGTx's xerostomia gene therapy By Investing.com - Investing.com Canada
MeiraGTx Holdings plc (MGTX) Receives RMAT Designation from FDA for AAV2-hAQP1 - Defense World
FDA grants RMAT status to MeiraGTx's xerostomia gene therapy - Investing.com India
MeiraGTx Secures Coveted FDA RMAT Status for Breakthrough Xerostomia Gene Therapy - StockTitan
MeiraGTx Holdings: Behind The Recent Rally (NASDAQ:MGTX) - Seeking Alpha
Erste Asset Management GmbH Takes $2.80 Million Position in MeiraGTx Holdings plc (NASDAQ:MGTX) - MarketBeat
MeiraGTx (NASDAQ:MGTX) Shares Gap UpHere's Why - MarketBeat
Knoll Capital Management LLC Buys Shares of 1,250,000 MeiraGTx Holdings plc (NASDAQ:MGTX) - MarketBeat
Chardan Capital Reiterates Buy Rating for MeiraGTx (NASDAQ:MGTX) - Defense World
Trend Tracker for (MGTX) - Stock Traders Daily
Analysts Have Lowered Expectations For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its Latest Results - Simply Wall St
MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
MeiraGTx Holdings Reports Significant Losses Amid Strategic Moves - TipRanks
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates - MSN
MeiraGTx wins 3 Rare Pediatric designations and updates on AAV-AIPL1 - The Pharma Letter
MeiraGTx Holdings plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MeiraGTx Holdings PLC Q3 2024 Earnings: Revenue Soars to $10.9M, EPS Misses Estimates at -$0.55 - GuruFocus.com
MeiraGTx Scores Triple FDA Designations, Reports Strong Parkinson's Data Despite Q3 Loss | MGTX Stock News - StockTitan
Jim Cramer: This Tech Stock Is A Buy, SoFi Technologies Is Good - Benzinga
Dynamic range: the key to MeiraGTx’s quest to control genes with pills - BioCentury
Duchenne Muscular Dystrophy Therapeutics Market Trends, Growth Insights, and Forecasts 2033 - WhaTech
Gene Therapy Market Detailed Analysis and Forecast to 2031 - InsightAce Analytic
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity - BioWorld Online
MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress - The Manila Times
4.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):